Barely Significant
← all excerpts

Pancreatic Enzyme Replacement and Nutritional Support With nab-Paclitaxel-based First-Line Chemotherapy Regimens in Metastatic Pancreatic Cancer.

Oncologist · 2023 · PMC10485404 · PMID 37155993

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

showed a trendno p-value reported
Patients who showed a trend in improved MUST score (ie, increased BMI or weight for any value) or improved phase angle (ie, increased value) at the first follow-up control, were defined as “adequate” support.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.